Urovo Technology Balance Sheet Health
Financial Health criteria checks 5/6
Urovo Technology has a total shareholder equity of CN¥1.5B and total debt of CN¥582.5M, which brings its debt-to-equity ratio to 38.7%. Its total assets and total liabilities are CN¥2.3B and CN¥827.0M respectively. Urovo Technology's EBIT is CN¥50.2M making its interest coverage ratio -7.3. It has cash and short-term investments of CN¥1.2B.
Key information
38.7%
Debt to equity ratio
CN¥582.53m
Debt
| Interest coverage ratio | -7.3x |
| Cash | CN¥1.17b |
| Equity | CN¥1.51b |
| Total liabilities | CN¥827.05m |
| Total assets | CN¥2.33b |
Recent financial health updates
Recent updates
Capital Allocation Trends At Urovo Technology (SZSE:300531) Aren't Ideal
Dec 25
Urovo Technology Co., Ltd.'s (SZSE:300531) Shares Climb 59% But Its Business Is Yet to Catch Up
Oct 08Is Urovo Technology (SZSE:300531) A Risky Investment?
Sep 27Optimistic Investors Push Urovo Technology Co., Ltd. (SZSE:300531) Shares Up 45% But Growth Is Lacking
Aug 23Urovo Technology (SZSE:300531) Will Want To Turn Around Its Return Trends
Jul 25Urovo Technology's (SZSE:300531) Dividend Will Be CN¥0.05
May 26Calculating The Intrinsic Value Of Urovo Technology Co., Ltd. (SZSE:300531)
Mar 27Urovo Technology Co., Ltd.'s (SZSE:300531) 27% Price Boost Is Out Of Tune With Earnings
Mar 06Capital Allocation Trends At Urovo Technology (SZSE:300531) Aren't Ideal
Feb 28Financial Position Analysis
Short Term Liabilities: 300531's short term assets (CN¥1.9B) exceed its short term liabilities (CN¥795.0M).
Long Term Liabilities: 300531's short term assets (CN¥1.9B) exceed its long term liabilities (CN¥32.1M).
Debt to Equity History and Analysis
Debt Level: 300531 has more cash than its total debt.
Reducing Debt: 300531's debt to equity ratio has increased from 22.9% to 38.7% over the past 5 years.
Debt Coverage: 300531's debt is well covered by operating cash flow (27.9%).
Interest Coverage: 300531 earns more interest than it pays, so coverage of interest payments is not a concern.
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/05 17:30 |
| End of Day Share Price | 2025/02/05 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Urovo Technology Co., Ltd. is covered by 4 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Zejing Liu | China Merchants Securities Co. Ltd. |
| Chunyang Wu | Everbright Securities Co. Ltd. |
| Chenglong Ma | Guosen Securities Co., Ltd. |